NCT03150472View on ClinicalTrials.gov

Safety and Efficacy Evaluation of the Ivory Dentin Graft Device

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

September 9, 2020

Study Completion Date

September 9, 2020

Conditions
Deficiency of Alveolar Ridge (Disorder)Alveolar Bone GraftingMandibular Prosthesis User
Interventions
DEVICE

Graft Matrix

Both Graft matrix products are supplied sterile, for single use only and packed in vials or a syringe-like applicator. All products consist of the same bone graft particles with the only variants being due to different amounts per package or different containers.

Trial Locations (1)

70300

Assaf HaRofeh Medical Center, Tel Aviv

All Listed Sponsors
lead

Ivory Graft Ltd.

INDUSTRY

NCT03150472 - Safety and Efficacy Evaluation of the Ivory Dentin Graft Device | Biotech Hunter | Biotech Hunter